| Quantity: | |
|---|---|
This product contains inactivated Mycoplasma hyopneumoniae Strain HN0613 with an antigen content of 9.0×10⁸·⁰ CCU per dose.
Pale yellow aqueous solution. A small amount of sediment may appear after long-term standing, which forms a homogeneous suspension after shaking thoroughly.
For the prevention of swine mycoplasmal pneumonia in pigs. The immune duration lasts 6 months.
Administer via intramuscular injection in the neck. For piglets aged 14 to 21 days, inject 2 mL per dose.
20 mL/bottle, 40 mL/bottle, 50 mL/bottle, 100 mL/bottle, 250 mL/bottle
Store at 2–8 °C. Shelf life: 18 months from the date of manufacture.
For use only under veterinary supervision.
1.Ultra-high antigen load and strong immune protection: Adopts high-quality HN0613 strain with ultra-high antigen content up to9.0×10⁸·⁰ CCU per dose. It efficiently induces high-level antibodies and rapidly builds a solid respiratory immune barrier against swine mycoplasma pneumonia.
2.Ultra-safe inactivated technology for early piglet vaccination: The inactivated vaccine features no viable bacteria and no virus reversion risk with high safety. It supports early vaccination for 14–21 day-old piglets to block early mycoplasma colonization and infection.
3.Long-lasting stable protection reduces breeding losses: It provides 6-month continuous immunity, effectively reducing cough, asthma, lung lesions and slow growth caused by mycoplasma infection, optimizing feed conversion ratio and improving fattening benefits.
4.Simple operation suitable for large-scale immunization: Conventional neck intramuscular injection with simple operation. The stable formulation with slight precipitation after shaking adapts to regular and large-scale vaccination in pig farms.
5.Convenient cold chain storage and low stocking cost: Store under conventional 2～8℃ refrigeration without freezing equipment. The 18-month long shelf life ensures long inventory cycle and reduces farm stocking pressure.
6.Diversified full-coverage specifications: Five large-capacity specifications fit small, medium and large-scale pig farms, realizing flexible use and zero vaccine waste.
A: This is an inactivated swine mycoplasma pneumonia vaccine (Strain HN0613), a non-prescription veterinary drug, specially used to prevent swine enzootic pneumonia caused by Mycoplasma hyopneumoniae.
Q: What is the antigen content standard of the vaccine? What are its core advantages?
A: The antigen content is as high as 9.0×10⁸·⁰ CCU per dose. The ultra-high antigen content rapidly activates immunity with high antibody level and more stable and durable protection.
Q: How long is the protection period after standard vaccination?
A: The immune duration can reach 6 months after standard vaccination, covering the key growth cycle of piglets and reducing repeated infection and booster times.
Q: What are the storage, transportation conditions and shelf life? What are the taboos?
A: Store at 2～8℃ away from light with a shelf life of 18 months. Freezing, high temperature and direct sunlight are strictly prohibited during storage and transportation.
Q: What are the key operation precautions before use?
A: Warm to room temperature and shake well before use, and implement sterile vaccination operation. Use up the vaccine once opened, and conduct harmless treatment for residual vaccine and appliances.
Q: What breeding scenarios is the vaccine applicable to? What specifications are available?
A: Five large-capacity specifications are available for batch vaccination in various small, medium and large-scale pig farms with wide adaptability and no usage waste.
